-
Ruel Jacob wrote a new post 6 days, 20 hours ago
Europacolon Portugal Successfully Implements Pilot Project The ‘+INTESTINO’ initiative, held from 16 – 27 October marked a significant step in promoting health and raising awareness about colorectal can […]
-
Ruel Jacob wrote a new post 4 months, 1 week ago
Act4Biosimilars: The Action Plan and Deep Dive Report for Europe are Now Live! Act4Biosimilars is a global initiative that aims to increase patient access to biologics by facilitating greater Approvability, Accessibility, […]
-
Ruel Jacob wrote a new post 5 months ago
EuropaColon Portugal Launched Support Line for Carers The data from the Caring for Informal Carers Movement surveys show that there are many issues facing these carers in Portugal, but one gap that s […]
-
Ruel Jacob wrote a new post 8 months, 2 weeks ago
RWE Research in mCRC In a recent article published in the Future Oncology, Patient Advocates and DiCE CEO Zorana Maravic explored and enhanced the understanding of the […]
-
Ruel Jacob wrote a new post 9 months, 2 weeks ago
Updates in Oesophageal and Gastric Cancer Research, Summer 2023
-
Ruel Jacob wrote a new post 10 months, 1 week ago
Join our Young CRC Patient Focus Group This year, DiCE is working on gaining additional insight into the experiences of young colorectal cancer patients, from symptoms to diagnosis to […]
-
Ruel Jacob wrote a new post 10 months, 1 week ago
Shaping Priorities for the EU4Health Funding Programme The Commission conducted in May a targeted consultation on the EU4Health programme’s future priorities, orientation, and needs. DiCE contributed […]
-
Ruel Jacob wrote a new post 10 months, 1 week ago
Croatian National Policy Event on Digestive Cancers
-
Ruel Jacob wrote a new post 11 months, 1 week ago
SURVEY: Assessing AI Awareness & Perceptions Among Patient Organisations European Patient’s Forum (EPF) is collecting responses to a survey addressed to patients’ organisations or individuals carrying out patient advocacy […]
-
Ruel Jacob wrote a new post 11 months, 2 weeks ago
Kick-Off Event for the SmartCARE Project
-
Ruel Jacob wrote a new post 11 months, 2 weeks ago
A Wind of Change in the EU's Pharmaceutical Landscape The challenge that the European Commission set itself up for in revising the EU’s Pharmaceutical Legislation (namely Directive 2001/83/EC1 and […]
-
Ruel Jacob wrote a new post 11 months, 2 weeks ago
Colores Finland Shares Effort to Support People Living with Lynch Syndrome
-
Ruel Jacob wrote a new post 11 months, 2 weeks ago
EuropaColon Poland Received "Swallow of Hope Award" Congratulations to our member organisation EuropaColon Poland Foundation for Patients, on receiving the “Swallow of Hope”, a national Polish awa […]
-
Ruel Jacob wrote a new post 11 months, 2 weeks ago
TOGAS: Towards Gastric Cancer Screening Implementation in the European Union
-
Ruel Jacob wrote a new post 11 months, 2 weeks ago
Liver Cancer Index – The Mapping Survey Is Available Online The survey was created to map the liver cancer treatment landscape across the EU and is now available online and disseminated among several relevant […]
-
Ruel Jacob wrote a new post 11 months, 2 weeks ago
Scientists Propose A Novel Approach For The Treatment Of Liver Cancer The Nature Cancer journal recently published promising results from cell and mouse studies by liver cancer specialists at the Massachusetts General […]
-
Ruel Jacob wrote a new post 11 months, 2 weeks ago
EuropaColon Slovenia Celebrates Its 15th Anniversary This March EuropaColon Slovenia rang in its 15th anniversary as a patient association! EC Slovenia was an original member of EuropaColon, the […]
-
Ruel Jacob wrote a new post 1 year ago
Primary Findings From The GLOW Study Signals Positive Momentum In The Development Of Novel Therapeutic Options For Patients With HER2-Negative Locally Advanced Unresectable Or Metastatic Gastric & GEJ Cancers At the end of 2022, leaders of the Phase 3 clinical trial GLOW shared their positive primary findings. GLOW (NCT03653507) is a global, multicenter, […]
-
Ruel Jacob wrote a new post 1 year ago
Trastuzumab Deruxtecan Meets Objective Response Rate Endpoint in Several Types of HER2-expressing Advanced Solid Tumours Positive topline results of the ongoing DESTINY-PanTumour02 Phase II trial (NCT04482309) showed that treatment with trastuzumab deruxtecan met the […]
-
Ruel Jacob wrote a new post 1 year ago
The First International Management Guidelines for Early-Onset Colorectal Cancer This March, the Clinical Gastroenterology and Hepatology journal published the first management guidelines for Early-Onset Colorectal Cancer […]
- Load More